FDA permits marketing of first catheter-based systems used to create vascular access for hemodialysis patients
(Source: Food and Drug Administration)
Source: Food and Drug Administration - June 22, 2018 Category: American Health Source Type: news

FDA approves automated insulin delivery and monitoring system for use in younger pediatric patients
(Source: Food and Drug Administration)
Source: Food and Drug Administration - June 21, 2018 Category: American Health Source Type: news

Nocdurna (desmopressin acetate) Approved by FDA as First Sublingual Tablet to Treat Nocturia due to Nocturnal Polyuria
Parsippany, NJ – June 21, 2018 – The U.S. Food and Drug Administration (FDA) granted Ferring Pharmaceuticals Inc. approval to market Nocdurna, the first sublingual tablet for the treatment of nocturia due to nocturnal polyuria in adults who... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 21, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves First Continuous Glucose Monitoring System with Fully Implantable Glucose Sensor
June 21, 2018 -- The U.S. Food and Drug Administration today approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of age and older with diabetes. This is the first FDA-approved CGM system to include a fully... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 21, 2018 Category: Pharmaceuticals Source Type: news

FDA approves first continuous glucose monitoring system with a fully implantable glucose sensor and compatible mobile app for adults with diabetes
glucose monitoring system, implantable glucose sensor, adults, diabetes (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 21, 2018 Category: American Health Source Type: news

Gaia Ethnobotanical, LLC., Voluntarily Recalls Kratom Products Due to Potential Salmonella Contamination
Gaia Ethnobotanical, LLC., is voluntarily recalling all kratom (mitragyna speciosa) powder products, with Lot No.: 0102031800 it manufactured, processed, packed, and/or held, between March 18, 2018 to March 30, 2018 to the consumer level. The products have been found by the U.S. Food and Drug Administration ( “FDA”) via sample testing and finding to have salmonella contamination. In lieu of such FDA findings the company has implemented standard operating procedures and sterilization processes in accordance to FDA guidelines. (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 21, 2018 Category: Food Science Source Type: news

FDA clears Siemens' syngo.via, Biograph mCT features
Siemens Healthineers has received U.S. Food and Drug Administration (FDA) clearance...Read more on AuntMinnie.comRelated Reading: Siemens installs 1st Biograph Vision PET/CT scanner ASRT Foundation, Siemens award travel grants Siemens gets FDA OK for Biograph Vision PET/CT Siemens leads $5M in financing for ScreenPoint Currency headwinds have impact on revenue at Siemens (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 21, 2018 Category: Radiology Source Type: news

Now Health Group Inc. Recalls Select Now Real Food ® Zesty Sprouting Mix Because of Possible Health Risk
NOW Health Group, Inc. (NOW), of Bloomingdale, Illinois, is recalling its NOW Real Food ® Zesty Sprouting Mix – Product Code 7271, Lot #3031259 and Lot #3038165 – because its primary ingredient, Crimson Clover Seeds, has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, a nd others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can res...
Source: Food and Drug Administration - June 21, 2018 Category: Food Science Source Type: news

Now Health Group Inc. Recalls Select Now Real Food ® Zesty Sprouting Mix Because of Possible Health Risk
NOW Health Group, Inc. (NOW), of Bloomingdale, Illinois, is recalling its NOW Real Food ® Zesty Sprouting Mix – Product Code 7271, Lot #3031259 and Lot #3038165 – because its primary ingredient, Crimson Clover Seeds, has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can resu...
Source: Food and Drug Administration - June 21, 2018 Category: Food Science Source Type: news

Scientists Are Using a New Weapon to Fight Drug-Resistant Bacteria —Viruses
A new medical research center in San Diego is embracing an innovative way to treat antibiotic resistant infections called bacteriophage therapy—phage therapy for short—which uses viruses as weapons against hard-to-treat infections. Antibiotic-resistant infections are part of a growing global health problem. Each year in the United States, at least two million people contract drug-resistant infections, and 23,000 die from those illnesses. Bacteria naturally grow resistant to the drugs used to treat them, and for people with especially tough infections that aren’t responding to the usual medications, the op...
Source: TIME: Health - June 21, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized healthytime medicine Source Type: news

Medtronic Announces Second Bone Cement Solution Indicated for Treating Sacral Fractures
Delivering Commitment to Find New Treatment Options for Patients Suffering from Sacral Insufficiency Fractures DUBLIN - June 20, 2018- Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of ... Devices, Interventional, Radiology, Orthopaedic, FDA Medtronic, Kyphon, Kyphon HV-R, Bone Cement, Sacral Insufficiency (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2018 Category: Pharmaceuticals Source Type: news

AIVITA Biomedical Announces U.S. Food and Drug Administration Clearance of IND for Phase II Glioblastoma Multiforme Trial
Trial Will Investigate Company's Platform Cancer Immunotherapy in Patients with The Deadliest Form of Brain Cancer IRVINE, Calif., June 20, 2018 -- (Healthcare Sales & Marketing Network) -- AIVITA Biomedical, a biotech company specializing in innovativ... Regenerative Medicine, Oncology, FDA AIVITA Biomedical, glioblastoma multiforme, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2018 Category: Pharmaceuticals Source Type: news

Many Drugs Made Available Via FDA Expanded Access Programs
WEDNESDAY, June 20, 2018 -- Over the past two decades, close to 100 U.S. Food and Drug Administration (FDA)-approved drugs and biologics were made available before FDA approval through expanded access programs, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 20, 2018 Category: Pharmaceuticals Source Type: news

Statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs in FDA ’s Center for Drug Evaluation and Research, on the agency’s response to ongoing drug shortages for critical products
Statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs in FDA ’s Center for Drug Evaluation and Research, on the agency’s response to ongoing drug shortages for critical products (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 19, 2018 Category: American Health Source Type: news

FDA calls for public comment on Pre-Cert working model
The U.S. Food and Drug Administration (FDA) is requesting public input on a...Read more on AuntMinnie.comRelated Reading: FDA issues medical device submission guidance FDA moves to reclassify CAD software to class II FDA works on new regulatory framework for AI FDA issues MR thermometry warning FDA proposes new path to 510(k) clearance (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 19, 2018 Category: Radiology Source Type: news

Golden Star Wholesale Issues Allergy Alert on Undeclared Sulfites in Dried Apricots Sour
Golden Star Wholesale of Troy, MI 48084 is recalling, AL Reef Dried Apricots Sour, because it may contain undeclared sulfites. People who have an allergy or severe sensitivity to sulfites run the risk of serious or life-threatening allergic reactions if they consume this product. (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 19, 2018 Category: Food Science Source Type: news

Fewer American Adults Are Smoking Than Ever Before
Smoking rates among U.S. adults have hit an all-time low, new estimates say. Approximately 14% of American adults said they were smokers last year, according to data from the Centers for Disease Control and Prevention’s National Center for Health Statistics (NCHS). While that’s still a significant number, encompassing more than 30 million Americans, it’s down from 16% the year before and roughly 20% in 2006. It’s also a significant drop-off from rates recorded around 50 years ago, which topped 40% by some estimates. Today, men are more likely to smoke than women, according to responses to the NCHS&r...
Source: TIME: Health - June 19, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime public health Source Type: news

Statement from FDA Commissioner Scott Gottlieb, M.D., on new guidance to help manufacturers implement protections against potential attacks on the U.S. food supply
FDA releases draft guidance to help food manufacturers implement the Intentional Adulteration rule under the FDA Food Safety Modernization Act (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 19, 2018 Category: American Health Source Type: news

Long-awaited FDA guidance addresses one key obstacle to value-based contracting
As part of the broader shift away from paying for volume to paying for value in health care, payors are increasingly pursuing value-based or results-based contracts with biopharmaceutical companies. These innovative payment arrangementscan help deliver savings for patients, private payors and the government in addition to the potential for better clinical outcomes. Recent, long-awaited final guidance from the U.S. Food and Drug Administration provides much-needed clarity in engaging in the communications that facilitate these arrangements. (Source: The Catalyst)
Source: The Catalyst - June 19, 2018 Category: Pharmaceuticals Authors: Jim C. Stansel Source Type: news

USFDA approves first product from Glenmark's US plant
The US Food and Drug Administration has provided its first supplemental Abbreviated New Drug Application approval for the company's plant in Monroe, Glenmark (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 19, 2018 Category: Pharmaceuticals Source Type: news

Foodborne Illness Advisory: Honey Smacks Cereal Linked to Salmonella Outbreak
The Wisconsin Department of Health Services (DHS), Wisconsin Department of Agriculture, Trade and Consumer Protection (DATCP), and local health departments are working with the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention (CDC) to investigate a multistate outbreak ofSalmonella Mbandaka infections linked to the consumption of Kellogg ’s Honey Smacks cereal. To date, there has been one confirmed case of Salmonella...(see release) (Source: Wisconsin DHFS Press Releases)
Source: Wisconsin DHFS Press Releases - June 18, 2018 Category: Hospital Management Authors: millejcodn Source Type: news

‘Supercharged’ Immunotherapy Could Target Mesothelioma Cell Protein
Standard mesothelioma treatment options include surgery, radiation therapy, chemotherapy and multimodal therapy. These standard therapies do not offer a cure for people with mesothelioma, and that’s why scientists continue searching for better ways to treat the disease. Researchers at the Scripps Research Institute in Jupiter, Florida, have created a precision medicine approach that targets a protein on the surface of cancer cells to kill tumors. Although the drug was not specifically designed for mesothelioma patients, it may offer a more effective way to manage the disease in the future. The treatment is a type of...
Source: Asbestos and Mesothelioma News - June 18, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Proposed Remetinostat Phase III Design Results in Delay in Planned Start of Study
STOCKHOLM, June 18, 2018 -- (Healthcare Sales & Marketing Network) -- Medivir AB (Nasdaq Stockholm: MVIR) today announced that the Board of Directors have decided to continue the discussions with the US Food and Drug Administration (FDA) to agree on the d... Biopharmaceuticals, Oncology Medivir, remetinostat, cutaneous T-cell lymphoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Israel's DreaMed gets FDA ok for diabetes management software
TEL AVIV (Reuters) - Israel's DreaMed Diabetes said on Monday the U.S. Food and Drug Administration has approved for marketing its Advisor Pro software to help manage diabetes treatment. (Source: Reuters: Health)
Source: Reuters: Health - June 18, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Health Tip: Soothing Baby During Teething
-- Teething is a normal part of an infant's life, but it doesn't come without some pain and discomfort. The U.S. Food and Drug Administration cautions against applying medication directly to the gums. Products such as the numbing agent benzocaine... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 18, 2018 Category: General Medicine Source Type: news

Infectious Diseases A-Z: Salmonella infection
Salmonella?infection is one of the most common forms of foodborne illness in the U. S. The?Centers for Disease Control and Prevention (CDC)?estimates 1 million people become sick and 380 people die each year from the bacterial disease. Currently the CDC and the US Food and Drug Administration have issued warnings of a multi-state salmonella outbreak [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 18, 2018 Category: Databases & Libraries Source Type: news

Del Monte Fresh Produce N.A., Inc. Voluntarily Recalls Limited Quantity of Vegetable Trays in a Multistate Outbreak of Cyclospora Illnesses in Select Retailers in Illinois, Indiana, Iowa, Michigan, Minnesota, and Wisconsin, Because of Possible Health Risk
Del Monte Fresh Produce N.A., Inc. ( " Del Monte Fresh " ) announced today, the voluntary recall of a limited quantity of 6 oz., 12 oz. and 28 oz. vegetable trays containing fresh broccoli, cauliflower, celery sticks, carrots, and dill dip sold to select retailers in Illinois, Indiana, Iowa, Michigan, Minnesota and Wisconsin. Del Monte was notified by state agencies of the outbreak and its potential involvement. (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 16, 2018 Category: Food Science Source Type: news

FDA Approves First Generic Under-the-Tongue Suboxone
FRIDAY, June 15, 2018 -- The first generic version of an under-the-tongue film to treat opioid addiction has been approved by the U.S. Food and Drug Administration. The generic version of Suboxone (buprenorphine and naloxone) film from Mylan... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 15, 2018 Category: Pharmaceuticals Source Type: news

Melons Are Being Recalled Over Salmonella Fears in More Than 20 States
The U.S. Food and Drug Administration is warning consumers in more than 20 states not to eat certain fruit salad mixes that contain pre-cut melons due to a salmonella outbreak. The pre-cut melon products are being recalled by Caito Foods, LLC. from grocery stores across 23 states. The salmonella outbreak has affected 60 people, primarily from the Midwest. Thirty-one people have been hospitalized, according to the Centers for Disease Control and Prevention. The FDA advises avoiding fresh cut watermelon, honeydew, cantaloupe and any packaged product containing those melons for those located in Alabama, California, Florida, G...
Source: TIME: Health - June 15, 2018 Category: Consumer Health News Authors: Mahita Gajanan Tags: Uncategorized onetime Recalls Source Type: news

Harvard, MIT launch effort to make the FDA more efficient
When the U.S. Food and Drug Administration began monitoring drug safety in 1937, the industry looked markedly different than it does today. Genetic therapies and enzyme treatments had not been invented, much less analyzed for their safety. A new partnership between Harvard Medical School and MIT seeks to modernize how the federal government permits, analyzes and evaluates whether drugs are safe and effective. “It’s making the system work better," said Brian Alexander, associate professor of… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 15, 2018 Category: Biotechnology Authors: Jessica Bartlett Source Type: news

Medtronic Receives FDA Approval for 200mm and 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons
New, Extended Balloon Lengths Enable Physicians to Efficiently Treat Long SFA Lesions DUBLIN - June 15, 2018 - Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for 200mm and 250mm lengths of... Devices, Interventional, FDA Medtronic, IN.PACT Admiral, Drug-Coated Balloon, peripheral artery disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 15, 2018 Category: Pharmaceuticals Source Type: news

Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner Anna Abram on emerging food innovation, “cultured” food products
Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner Anna Abram on emerging food innovation, “cultured” food products (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 15, 2018 Category: American Health Source Type: news

Indivior shares dive after Dr Reddy's gets FDA approval for generic
(Reuters) - Britain's Indivior fell by more than 20 percent on Friday after the U.S Food and Drug Administration (FDA) approved the first generic versions of Suboxone Film, an opioid addiction treatment that generates 80 percent of its revenue. (Source: Reuters: Health)
Source: Reuters: Health - June 15, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

FDA warns consumers in 10 more states not to eat cut melon due to salmonella
Alabama, California, Florida, Kansas, Maryland, Minnesota, Nebraska, North Dakota, South Dakota and Tennessee have been added to the list of states where cut melon may be contaminated with salmonella, the Food and Drug Administration said Thursday. This brings the total number of states to 23. (Source: CNN.com - Health)
Source: CNN.com - Health - June 14, 2018 Category: Consumer Health News Source Type: news

Kellogg Company Voluntarily Recalls Honey Smacks Cereal Due to Possible Health Risk
Kellogg Company today announced it is voluntarily recalling 15.3 oz. and 23 oz. packages of Kellogg ’s® Honey Smacks® cereal (with code dates listed below) because these products have the potential presence of Salmonella. No other Kellogg products are impacted by this recall. (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 14, 2018 Category: Food Science Source Type: news

FDA approves first generic versions of Suboxone sublingual film, which may increase access to treatment for opioid dependence
: FDA approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film (applied under the tongue) for the treatment of opioid dependence. (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 14, 2018 Category: American Health Source Type: news

FDA Approves First Generic Versions of Suboxone Sublingual Film, Which May Increase Access to Treatment for Opioid Dependence
June 14, 2018 -- The U.S. Food and Drug Administration today approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film (applied under the tongue) for the treatment of opioid dependence. “The FDA is taking new... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 14, 2018 Category: Pharmaceuticals Source Type: news

Merz NA CEO talks plans from Raleigh HQ
After heading into 2018 with a new U.S. Food and Drug Administration clearance and an expanded sales force, Merz NA has made a pair of new skincare line launches. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 14, 2018 Category: Health Management Authors: Jennifer Henderson Source Type: news

Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency ’s efforts to better equip consumers with nutritional information about dietary fiber in their food
Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency ’s efforts to better equip consumers with nutritional information about dietary fiber in their food (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 14, 2018 Category: American Health Source Type: news

Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency ’ s efforts to better equip consumers with nutritional information about dietary fiber in their food
Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency ’ s efforts to better equip consumers with nutritional information about dietary fiber in their food (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 14, 2018 Category: American Health Source Type: news

Results of Novel Mesothelioma Drug Presented at ASCO Meeting
A multicenter phase II clinical trial involving the latest orally administered protein inhibitor drug has shown considerable promise in helping control malignant mesothelioma. The effectiveness of tazemetostat was presented last week at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago. The trial study, which will conclude late 2018, involves 74 previously treated patients with recurring mesothelioma. “We’ve seen benefit for some patients with this treatment and patients who have benefited over a long period of time,” medical oncologist Dr. Marianna Koczywas, City of Hope Cancer T...
Source: Asbestos and Mesothelioma News - June 14, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

World Variety Produce, Inc. Voluntarily Recalls Spicy Edamame Because Of Undeclared Allergens
World Variety Produce, Inc. of Los Angeles, CA is voluntarily recalling Spicy Edamame 7oz, because it contains the undeclared shellfish/crustacean allergen “Oyster Extract” ingredient within the spicy sauce packet. People who have an allergy or severe sensitivity to shellfish run the risk of serious or life-threatening allergic reaction if they consume these products. (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 13, 2018 Category: Food Science Source Type: news

FDA approves Roche ’s Avastin (bevacizumab) plus chemotherapy as a treatment for women with advanced ovarian cancer following initial surgery
Roche today announced that the US Food and Drug Administration (FDA) has approved Avastin ® (bevacizumab) in combination with chemotherapy (carboplatin and paclitaxel), followed by Avastin as a single agent, for the treatment of women with advanced (stage III or IV) ovarian cancer following initial surgical resection. (Source: Roche Media News)
Source: Roche Media News - June 13, 2018 Category: Pharmaceuticals Source Type: news

FDA approves Roche ’s Avastin (bevacizumab) plus chemotherapy as a treatment for women with advanced ovarian cancer following initial surgery
Roche today announced that the US Food and Drug Administration (FDA) has approved Avastin ® (bevacizumab) in combination with chemotherapy (carboplatin and paclitaxel), followed by Avastin as a single agent, for the treatment of women with advanced (stage III or IV) ovarian cancer following initial surgical resection. (Source: Roche Investor Update)
Source: Roche Investor Update - June 13, 2018 Category: Pharmaceuticals Source Type: news

FDA grants Cary's Chiesi new designation
With construction of a new headquarters overlooking Symphony Lake currently underway, expanding Cary-based pharmaceutical company Chiesi USA has received a nod from the U.S. Food and Drug Administration for a new stem cell therapy. Chiesi USA – along with Italian biotech Holostem Terapie Avanzate – have been granted orphan drug designation from the FDA for an investigational therapy for a type of stem cell deficiency. The therapy – called GPLSCD01 – is being developed to treat Limbal Stem… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 13, 2018 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news

What Cindy Eckert has planned with Sprout, Addyi back in hands
It ’s take two for Sprout Pharmaceuticals and Addyi, the only drug approved by the U.S. Food and Drug Administration to treat low sexual desire disorder in women.  With Sprout back in its former shareholder hands from Valeant Pharmaceuticals (NYSE: VRX), and former CEO Cindy Eckert (formerly Whiteh ead) back at its helm, Addyi relaunched Monday from its previous base in the CapTrust Tower at North Hills. “The baby is back, and I’m making some radical changes,” Eckert says. “This has always… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 13, 2018 Category: American Health Authors: Jennifer Henderson Source Type: news

MD Anderson, Houston Methodist scientists detect new ovarian cancer target
(University of Texas M. D. Anderson Cancer Center) Researchers at Houston Methodist Research Institute and The University of Texas MD Anderson Cancer Center have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 13, 2018 Category: International Medicine & Public Health Source Type: news

FDA Approves Genentech ’s Avastin (bevacizumab) Plus Chemotherapy as a Treatment for Women With Advanced Ovarian Cancer Following Initial Surgery
South San Francisco, CA -- June 13, 2018 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Avastin ® (bevacizumab) in combination with chemotherapy... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 13, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Keytruda (pembrolizumab) for Treatment of Refractory or Relapsed Primary Mediastinal Large B-Cell Lymphoma (PMBCL)
KENILWORTH, N.J.--(BUSINESS WIRE) June 13, 2018 --Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, the company ’s anti-PD-1 therapy, for the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 13, 2018 Category: Drugs & Pharmacology Source Type: news

Lupin launches generic antibiotic inhalation solution in US
The company has launched the product as it has received an approval from the US Food and Drug Administration (USFDA) earlier, Lupin said in a filing to BSE. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 13, 2018 Category: Pharmaceuticals Source Type: news